Immatics (IMTX) PT Raised to $14 at BofA Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Immatics (IMTX) PT Raised to $24 at Jefferies
November 13, 2025 4:30 AM ESTJefferies analyst Biren Amin raised the price target on Immatics (NASDAQ: IMTX) to $24.00 (from $20.00) while maintaining a Buy rating.
The analyst comments "IMTX shares have moved higher since Sep (+80%+ vs XBI +20%) on cont'd execution and spotlight on its Anzu-cel PRAME cell therapy data at... More
